ADMP Key Statistics, Chart & Performance
The current stock price of ADMP is 0.7751 USD. In the past month the price decreased by -42.59%. In the past year, price decreased by -96.65%.
ADMP Technical Analysis
ADMP Financial Highlights
Over the last trailing twelve months ADMP reported a non-GAAP Earnings per Share(EPS) of -11.03. The EPS increased by 40.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ADMP Forecast & Estimates
6 analysts have analysed ADMP and the average price target is 0.43 USD. This implies a price decrease of -44.73% is expected in the next year compared to the current price of 0.7751.
ADMP Ownership
ADMP Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 33.05 | 948.651B | ||
| JNJ | JOHNSON & JOHNSON | 20.28 | 561.608B | ||
| MRK | MERCK & CO. INC. | 22.11 | 287.517B | ||
| PFE | PFIZER INC | 8.87 | 146.521B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.48 | 113.982B | ||
| ZTS | ZOETIS INC | 18.56 | 53.945B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.35 | 24.804B | ||
| VTRS | VIATRIS INC | 5.72 | 15.756B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.27 | 12.098B | ||
| AXSM | AXSOME THERAPEUTICS INC | 228.39 | 9.444B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ADMP
Company Profile
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company is headquartered in San Diego, California and currently employs 11 full-time employees. Its products in the allergy, respiratory and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg, SYMJEPI (epinephrine) Injection 0.15mg and ZIMHI (naloxone HCL Injection, USP) 5 mg/0.5 mL. SYMJEPI (epinephrine) Injection 0.3mg is approved by the United States Food and Drug Administration (FDA) for use in the emergency treatment of acute allergic reactions, including anaphylaxis, for patients weighing 66 pounds or more. SYMJEPI (epinephrine) Injection 0.15mg is approved by the FDA for use in the treatment of anaphylaxis for patients weighing 33-65 pounds. ZIMHI (naloxone HCL Injection, USP) 5 mg/0.5 mL is approved by the FDA for the treatment of opioid overdose. The firm's Tempol, is an investigational drug.
Company Info
ADAMIS PHARMACEUTICALS CORP
Suite 310, 11455 El Camino Real
San Diego CALIFORNIA 92130 US
CEO: Dennis J. Carlo
Employees: 11
Phone: 18589972400.0
ADAMIS PHARMACEUTICALS CORP / ADMP FAQ
What does ADAMIS PHARMACEUTICALS CORP do?
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company is headquartered in San Diego, California and currently employs 11 full-time employees. Its products in the allergy, respiratory and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg, SYMJEPI (epinephrine) Injection 0.15mg and ZIMHI (naloxone HCL Injection, USP) 5 mg/0.5 mL. SYMJEPI (epinephrine) Injection 0.3mg is approved by the United States Food and Drug Administration (FDA) for use in the emergency treatment of acute allergic reactions, including anaphylaxis, for patients weighing 66 pounds or more. SYMJEPI (epinephrine) Injection 0.15mg is approved by the FDA for use in the treatment of anaphylaxis for patients weighing 33-65 pounds. ZIMHI (naloxone HCL Injection, USP) 5 mg/0.5 mL is approved by the FDA for the treatment of opioid overdose. The firm's Tempol, is an investigational drug.
Can you provide the latest stock price for ADAMIS PHARMACEUTICALS CORP?
The current stock price of ADMP is 0.7751 USD. The price increased by 0.86% in the last trading session.
Does ADMP stock pay dividends?
ADMP does not pay a dividend.
What is the ChartMill rating of ADAMIS PHARMACEUTICALS CORP stock?
ADMP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What sector and industry does ADAMIS PHARMACEUTICALS CORP belong to?
ADAMIS PHARMACEUTICALS CORP (ADMP) operates in the Health Care sector and the Pharmaceuticals industry.
Would investing in ADAMIS PHARMACEUTICALS CORP be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ADMP.
What is the market capitalization of ADMP stock?
ADAMIS PHARMACEUTICALS CORP (ADMP) has a market capitalization of 2.16M USD. This makes ADMP a Nano Cap stock.